Krajina: Írsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
ALTRENOGEST
Intervet Ireland Limited
QG03DX90
ALTRENOGEST
4 Mg/Ml
Oral Solution
POM
Porcine
Altrenogest
Hormone
Authorised
2017-04-28
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Folliplan, 4 mg/ml oral solution for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE INGREDIENT: Altrenogest 4.0 mg EXCIPIENTS: Butylhydroxytoluene (E321) 0.07 mg Butylhydroxyanisole (E320) 0.07 mg For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Oral solution. Clear, yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pig (sexually mature gilts) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the synchronisation and control of oestrus in cycling gilts. 4.3 CONTRAINDICATIONS Do not use in male pigs. Do not administer to pregnant sows or those suffering from uterine infection. Do not use in case of hypersensitivity to the active substance. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _8_ _/_ _0_ _4_ _/_ _2_ _0_ _1_ _7_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _2_ _2_ _8_ _8_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals To use only in sexually mature gilts who had already presented one oestrus. Special precautions to be taken by the person administering the veterinary medicinal product to animals - Women who are, or may be pregnant, should not use the product. Women of childbearing age should avoid contact with the product. - This product should not be handled by persons with known or suspected progesterone-dependent t Prečítajte si celý dokument